Defibtech competitors

Michael A. Mussallem, age 56, has been chairman and CEO of Edwards Lifesciences, Inc. since 2000. Prior to 2000, Mussallem held a variety of positions with increasing responsibility in engineering, product development and senior management at Baxter International Inc., including Group Vice President of its CardioVascular business from 1994 to 2000 and Group Vice President of the Biopharmaceutical business from 1998 to 2000. From 1996 until 1998, he was the Chairman of Baxter's Asia Board overseeing Baxter's operations throughout Asia. Mr. Mussallem is chairman of the board of directors of the Advanced Medical Technology Association (AdvaMed), and serves as a member of the board for Advanced Medical Optics. He is also on the boards and executive committees of the California Healthcare Institute and OCTANe, and is a trustee of the University of California, Irvine Foundation. He received a bachelor's degree in chemical engineering in 1974 and an honorary doctorate in 1999 from the Rose-Hulman Institute of Technology in Indiana.

Bill Valle is Executive Vice President of Fresenius Medical Care North America (FMCNA) and President of Fresenius Medical Services (FMS), the largest division of FMCNA. He is responsible for the successful management of more than 2,150 outpatient facilities, 1,400 inpatient programs, and 800 home dialysis programs across the U.S. Approximately 165,000 dialysis patients receive life-sustaining dialysis therapy in these facilities. Bill previously served as President of Fresenius Medical Care Integrated Renal Services. In that capacity, he led several of the organization’s vital business functions, integrating them into a high performance renal network that can improve the outcomes and reduce the costs of managing renal disease. These include Fresenius Vascular Care, FreseniusRx, Spectra Laboratories, FMS Business Development, FMS Inpatient Services and FMS Real Estate and Construction Services. Prior to joining FMCNA, Bill had 22 years of experience in the dialysis industry, serving in executive roles in sales, marketing and business development, as well as ownership in several private dialysis centers.

President/CEO with proven track record of value creation and consistently delivering outstanding results amid challenging situations. Combines strong strategic mindset with a relentless focus on execution. Committed to developing high-performing teams and a winning culture. Experienced in leading capital equipment, disposables, and implantables businesses within public and private equity capital structures. Have transformed businesses and sold to strategic acquirers at attractive valuations.

Kaylie is a student University of Mississippi graduating in 2021 and is based in Oxford, Mississippi. She is a Student Worker at CIE Ole Miss and Chief Executive Officer at HEARTWARE INTERNATIONAL, INC.. Kaylie attended Southport High School between 2014 and 2018.

Geoff Martha is firmly establishing Medtronic as the undisputed global leader in healthcare technology. As chairman & CEO, Geoff leads the $30 billion company and its 90,000 employees in pursuit of fulfilling the Medtronic Mission to use technology to improve human welfare. He is recognized as a driven and innovative executive - ranking in Modern Healthcare’s 100 Most Influential People in Healthcare in 2020 and listed as the #1 CEO in healthcare technology by the Healthcare Technology Report in 2021.Geoff became CEO in April 2020. Under his leadership, Medtronic is putting the ‘tech’ in MedTech, leveraging the latest advances in cutting edge technology to transform healthcare. Fortune Magazine named Medtronic among the top 15 companies for its 2020 “Change the World” list, recognizing its swift efforts during the pandemic, and listed the company on its 2021 list of Most Admired Companies.Geoff joined Medtronic in 2011, and notably led the acquisition and integration of Covidien, the largest acquisition in the medical technology industry. Before joining Medtronic, Geoff spent 19 years at GE Healthcare and GE Capital.Geoff is a member of the Business Roundtable, and the World Economic Forum’s International Business Council. He also co-chairs the Taskforce on Health and Life Sciences for B20, a G20 engagement group.An ardent supporter of philanthropic and diversity initiatives, Geoff serves on the board of directors for the Medtronic Foundation, Children’s HeartLink, and the Northside Achievement Zone. He is part of OneTen, a coalition of cross-industry leaders committed to breaking down systemic barriers for Black Americans. He also serves as Medtronic’s Executive Sponsor to FIRST Robotics.Geoff received a bachelor’s degree in Finance from Pennsylvania State University, where he currently serves on the Development Council for its College of Liberal Arts. He was also captain of the Penn State men’s hockey team and later inducted into its Hockey Hall of Fame.

Declan O'Mahoney is a member of the board of directors of the 1394 Trade Association and was founder and first chairman of the RBWG (Residential Backbone Working Group) of the 1394TA. Throughout his career, Declan has held executive positions in sales and marketing in major multinational companies within the electronics industry. Prior to joining Firecomms, Declan spent five years in Santa Clara, California as president of Northstar Systems Corporation where he piloted a worldwide sales and engineering team to fast growth in the computer and IT market segments. As a founding member of Northstar, he played a key role in the company’s substantial growth to over US$60M in sales, manufacturing facilities in Asia and over 2000 employees worldwide.